Challenges for the application of pharmacogenomics associated with the nomenclature of allelic variants

References

• 1. Bishop JR. Pharmacogenetics. In: Handbook of Clinical Neurology (Volume 147). Elsevier BV, Amsterdam, The Netherlands, 59–73 (2018).
  Google Scholar
• 2. Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature 526(7573), 343–350 (2015).
  Medline CASGoogle Scholar
• 3. Shirts BH, Salama JS, Aronson SJ et al. CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record. J. Am. Med. Informatics Assoc. 22(6), 1231–1242 (2015).
  MedlineGoogle Scholar
• 4. Poo DCC, Cai S, Mah JTL. UASIS: universal automatic SNP identification system. Presented at: Asia Pacific Bioinformatics Network (APBioNet) Tenth International Conference on Bioinformatics – FirstISCB Asia Joint Conference 2011 (InCoB/ISCB-Asia 2011). Kuala Lumpur, Malaysia, 30 November – 2 December 2011.
  Google Scholar
• 5. Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17(5), 405–424 (2015).
  MedlineGoogle Scholar
• 6. Lee KC, Ma JD, Kuo GM. Pharmacogenomics: bridging the gap between science and practice. J. Am. Pharm. Assoc. 50(1), e1–e17 (2010).
  MedlineGoogle Scholar
• 7. Caudle K, Klein T, Hoffman J et al. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr. Drug Metab. 15(2), 209–217 (2014).
  Medline CASGoogle Scholar
• 8. Gaedigk A, Whirl-Carrillo M, Pratt VM, Miller NA, Klein TE. PharmVar and the landscape of pharmacogenetic resources. Clin. Pharmacol. Ther. 107(1), 43–46 (2020).
  MedlineGoogle Scholar
• 9. Gaedigk A, Casey ST, Whirl-Carrillo M, Miller NA, Klein TE. PharmVar: a global resource and repository for pharmacogene variation. Clin. Pharmacol. Ther. 110(3), 542–545 (2021).
  MedlineGoogle Scholar
• 10. Nelson SC, Doheny KF, Laurie CC, Mirel DB. Is ‘forward’ the same as ‘plus’?...and other adventures in SNP allele nomenclature. Trends Genet. 28(8), 361–363 (2012).
  Medline CASGoogle Scholar
• 11. Kalman LV, Agúndez JAG, Appell ML et al. Pharmacogenetic allele nomenclature: international workgroup recommendations for test result reporting. Clin. Pharmacol. Ther. 99(2), 172–185 (2016).
  Medline CASGoogle Scholar
• 12. Ma JD, Lee KC, Kuo GM. Clinical application of pharmacogenomics. J. Pharm. Pract. 25 (4), 417–427 (2012).
  MedlineGoogle Scholar
• 13. Malentacchi F, Mancini I, Brandslund I et al. Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. Clinic. Chem. Lab Med 53(7), 981–988 (2015).
  Medline CASGoogle Scholar
• 14. Ayati N, Afzali M, Hasanzad M, Kebriaeezadeh A, Rajabzadeh A, Nikfar S. Pharmacogenomics implementation and hurdles to overcome; in the context of a developing country. Iran. J. Pharm. Res. 20(4), 92–106 (2021).
  MedlineGoogle Scholar
• 15. Heale BSE, Khalifa A, Stone BL, Nelson S, Del Fiol G. Physicians' pharmacogenomics information needs and seeking behavior: a study with case vignettes. BMC Med. Inform. Decis. Mak. 17(1), 113 (2017).
  MedlineGoogle Scholar
• 16. Caudle KE, Dunnenberger HM, Freimuth RR et al. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Genet. Med. 19(2), 215–223 (2017).
  MedlineGoogle Scholar
• 17. Etchegary H, Wilson B. Bringing personalized medicine to the community through public engagement. Per. Med. 10(7), 647–659 (2013).
  CASGoogle Scholar
• 18. Moyer AM, Caraballo PJ. The challenges of implementing pharmacogenomic testing in the clinic. Expert Rev. Pharmacoeconomics Outcomes Res. 17(6), 567–577 (2017).
  MedlineGoogle Scholar